Stable Isotope Labeled Peptides

Stable Isotope Labeled Peptides

GMP-compatible Peptide Standards13C 15N Labeled PeptidesMethod ValidationBiomarker Quantification

At Creative Peptides, we specialize in the custom synthesis of stable isotope labeled peptides, providing high-precision internal standards and reference materials for quantitative proteomics, bioanalysis, and regulated pharmaceutical research. By incorporating non-radioactive isotopes such as 13C, 15N, and 2H at defined amino acid positions, our expert chemists deliver peptides with identical chemical behavior to native counterparts while enabling accurate mass differentiation by LC-MS/MS. Serving pharmaceutical companies, biotechnology enterprises, and contract research organizations worldwide, we offer scalable, reproducible, and fully documented isotope-labeled peptide solutions to support method development, validation, and routine analysis.

What Problems Does This Technology Solve?

Quantitative protein and peptide analysis in complex biological samples is often limited by matrix effects, ion suppression, variable digestion efficiency, and instrument-related signal fluctuation.

Stable isotope labeled peptides directly address these analytical challenges by:

Improving quantitative accuracy: Isotope-labeled peptides co-elute with endogenous analytes and correct for sample loss, ionization variability, and matrix interference.

Enabling robust method validation: Widely accepted as gold-standard internal standards for bioanalytical method development, qualification, and regulatory submission.

Enhancing inter-laboratory reproducibility: Consistent isotopic incorporation and defined purity ensure reliable data comparison across studies and sites.

Supporting regulated workflows: Non-radioactive stable isotopes meet safety, handling, and compliance requirements for GMP, GLP, and preclinical research environments.

Our Stable Isotope Labeled Peptide Service Offerings

We offer enterprise-focused stable isotope labeled peptide solutions designed to support quantitative proteomics, regulated bioanalysis, and long-term biomarker programs. Our services are built around the real-world needs of pharmaceutical companies, biotechnology enterprises, and CROs—where analytical accuracy, reproducibility, documentation, and supply continuity are critical. Each project is supported by experienced peptide chemists and bioanalytical specialists with deep understanding of LC-MS/MS–based quantification workflows.

Target Peptide Selection & Quantification Strategy Support

Selecting the right peptide standard is essential for reliable quantitative analysis. Our team supports customers at the assay-design stage to ensure isotope-labeled peptides are fit for purpose.

Review and selection of proteotypic peptides based on sequence uniqueness, digestion behavior, and MS response.

Guidance on isotope choice (13C, 15N, 2H) and labeling pattern to achieve optimal mass separation without altering chromatographic behavior.

Alignment with analytical platforms including SRM/MRM, PRM, DIA, and absolute quantification (AQUA).

Support for single-analyte assays or multi-peptide quantitative panels.

This consultative approach reduces assay redevelopment risk and accelerates method validation timelines.

Stable Isotope Labeled Peptide Manufacturing

We manufacture stable isotope labeled peptides using solid-phase peptide synthesis with qualified isotope-labeled amino acid building blocks to ensure accurate incorporation and consistent performance.

Site-specific or uniformly labeled peptides with high isotopic enrichment.

Support for tryptic peptides, extended sequences, and analytically challenging regions.

Preparative RP-HPLC purification tailored to quantitative MS requirements.

Manufacturing controls designed to ensure batch-to-batch reproducibility.

All products are suitable for use as internal standards in complex biological matrices.

Modified and Application-Specific Labeled Peptides

To accurately reflect endogenous analytes, we supply isotope-labeled peptides incorporating biologically or analytically relevant modifications.

Phosphorylated, acetylated, methylated, and oxidized peptide standards for PTM quantification.

Heavy-labeled peptides compatible with enzymatic digestion workflows.

Peptides designed for biomarker validation, pathway analysis, and signaling studies.

Custom peptide panels supporting multiplexed quantitative assays.

These solutions are commonly applied in translational research, biomarker qualification, and preclinical assay development.

Analytical Qualification & Documentation

Each isotope-labeled peptide is analytically qualified to ensure suitability for quantitative and regulated workflows.

Analytical HPLC for purity assessment and batch comparison.

High-resolution LC-MS confirmation of sequence, molecular weight, and isotopic distribution.

Verification of isotopic enrichment and absence of unlabeled interference.

Certificate of Analysis including purity, identity, and labeling information.

Documentation is designed to support internal QA review, method validation, and regulatory submissions.

Program-Based Supply, Scale-Up & Lifecycle Support

For enterprise programs requiring long-term consistency, we provide structured supply and lifecycle management solutions.

Multi-milligram to gram-scale manufacturing to support development and routine testing.

Reserved lots and repeat manufacturing to ensure continuity across studies.

Change-control awareness for sequence, labeling, or process updates.

Long-term supply support for validated commercial assays.

Isotope Labeling Strategies for Quantitative Peptide Analysis

Selecting an appropriate isotope labeling strategy is a foundational decision in quantitative LC-MS/MS assay design. The choice influences mass separation, chromatographic behavior, method robustness, and long-term assay transferability. Enterprise laboratories typically evaluate labeling strategies based on analytical risk, matrix complexity, regulatory expectations, and program scale.

Single-residue heavy label

13C / 15N Lys or Arg

Targeted SRM/MRM or PRM assays

Predictable mass shift and co-elution for routine quantification

Confirm sufficient separation from natural isotopic envelope

Multi-residue heavy label

13C / 15N on multiple residues

Complex matrices or interference-prone assays

Improves selectivity and signal discrimination

Balance increased cost vs. analytical benefit

Uniform peptide labeling

Multiple 13C / 15N residues

Absolute quantification in highly complex samples

Maximum mass separation and inter-lab robustness

May be unnecessary for high-resolution instruments

Deuterium labeling

2H (D)

Cost-sensitive or legacy workflows

Lower material cost in some applications

Potential retention time shift due to isotope effects

Hybrid labeling

13C / 15N ± 2H

Custom or regulated biomarker assays

Flexible mass engineering for critical targets

Requires careful isotopic pattern validation

Types of Stable Isotope Labeled Peptide Standards

Stable isotope labeled peptide standards are deployed in different formats depending on assay design, analytical complexity, and regulatory context. Enterprise users typically select standard types based on how well they correct for variability across digestion, sample preparation, and LC-MS analysis.

AQUA-style heavy peptide

Targeted LC-MS/MS quantification

Ionization and matrix effects

Biomarker validation, translational research

Sequence and co-elution must match endogenous peptide

Multiplex peptide panels

Multi-analyte MRM/PRM assays

Run-to-run and inter-analyte variability

CRO studies, pathway profiling

Standardize concentration ranges across analytes

PTM-matched standards

PTM-specific quantification

Modification-dependent behavior

Signaling and MOA studies

Exact PTM site and chemistry must be matched

Surrogate peptides

Early discovery screens

Partial process variability

Feasibility and pilot assays

Not suitable for regulated quantification

Extended or domain peptides

Enrichment-based workflows

Recovery and processing bias

Immunoaffinity or pull-down assays

Confirm compatibility with enrichment reagents

Stable Isotope Labeled Peptides for Post-Translational Modifications

Post-Translational Modification often occur at low stoichiometry and are sensitive to sample handling and enrichment bias. Stable isotope labeled PTM peptides provide modification-specific internal standards that enable accurate, site-resolved quantification in both research and regulated analytical settings.

Phosphorylation

Cell signaling, kinase activity

Low abundance, enrichment variability

Enables site-specific, reproducible quantification

Protect against dephosphorylation during handling

Oxidation

Stress response, sample artifacts

Mixed oxidized/unoxidized populations

Supports accurate ratioing of oxidized forms

Define oxidation state explicitly

Acetylation

Epigenetics, protein regulation

Isobaric interference

Improves confidence in site localization

Confirm fragmentation strategy

Methylation

Chromatin and transcription control

Multiple methyl states

State-specific quantification

Separate mono/di/tri forms chromatographically

Deamidation

Stability and aging studies

Process-induced conversion

Controls analytical artifacts

Document handling conditions carefully

Quality Control and Documentation for Stable Isotope Labeled Peptides

Robust quality control and transparent documentation are essential for enterprise and regulated applications. Stable isotope labeled peptides used as quantitative standards must be fully characterized to ensure identity, purity, labeling integrity, and long-term reproducibility across studies and sites.

Identity confirmation

LC-MS

Correct sequence and molecular weight

Prevents assay failure due to wrong analyte

MS summary in CoA

Isotopic labeling verification

Isotopic pattern analysis

Correct isotope incorporation

Ensures distinguishable internal standard

Labeling statement

Purity assessment

Analytical HPLC

Impurity profile

Reduces quantification bias

HPLC chromatogram

Content assignment

UV or amino acid analysis

Peptide amount consistency

Critical for absolute quantification

Content statement

Co-elution check

LC comparison

Comparable chromatographic behavior

Valid internal standard correction

RT confirmation note

Traceability

Batch documentation

Lot and manufacturing history

Supports audits and long-term programs

Certificate of Analysis

Storage & handling guidance

Stability-informed recommendations

Integrity over time

Prevents revalidation and material loss

Handling instructions

Advantages of Our Stable Isotope Labeled Peptide Platform

Quantification-Focused Design

Peptides are designed specifically for quantitative LC-MS/MS workflows, ensuring co-elution and reliable internal standard performance.

High Isotopic Integrity

Use of qualified isotope-labeled amino acids delivers consistent mass shifts and reproducible isotopic distributions.

Application-Driven Expertise

Deep experience supporting biomarker validation, proteomics panels, and regulated bioanalytical assays.

Batch-to-Batch Consistency

Manufacturing controls and documentation support longitudinal studies and inter-site comparability.

Comprehensive QC & Documentation

Each peptide is supplied with a detailed Certificate of Analysis suitable for enterprise and regulated workflows.

Scalable Supply Capability

From milligram research quantities to program-level supply, supporting method validation and routine analysis.

Enterprise-Oriented Support

Familiarity with QA review, procurement requirements, and cross-functional program coordination.

Long-Term Program Reliability

Structured lifecycle and repeat-supply support reduces revalidation risk and operational disruption.

Trusted Partner Approach

Acting as a technical partner rather than a commodity supplier for critical quantitative standards.

General Workflow for Stable Isotope Labeled Peptide Projects

Our workflow for stable isotope labeled peptide projects is designed to ensure analytical accuracy, traceability, and consistency across discovery, development, and regulated bioanalytical stages. Each step is executed with close alignment to the customer's assay design, validation strategy, and long-term supply requirements.

1

Project Consultation & Assay Alignment

Review target proteins or peptide sequences, analytical platform (MRM, PRM, DIA), and intended use (research, validation, or regulated assays).

Define isotope labeling strategy, modification requirements, and quantity specifications.

2

Peptide Design & Isotope Labeling Strategy Confirmation

Selection of proteotypic peptide sequences and labeling positions to ensure co-elution and sufficient mass separation.

Confirmation of isotope type (13C, 15N, 2H) and enrichment level based on analytical requirements.

3

Stable Isotope Labeled Peptide Synthesis

Solid-phase peptide synthesis using qualified isotope-labeled amino acid building blocks.

Controlled synthesis and purification to ensure batch-to-batch consistency.

4

Analytical Characterization & Quality Verification

Confirmation of identity, isotopic distribution, purity, and labeling integrity by LC-MS and analytical HPLC.

Preparation of Certificate of Analysis and supporting documentation.

5

Delivery, Documentation & Lifecycle Support

Delivery of peptides with storage and handling guidance.

Support for repeat manufacturing, lot consistency, and long-term program supply.

Application Fields of Stable Isotope Labeled Peptides

Stable isotope labeled peptides are widely used as internal standards and reference materials to enable accurate, reproducible quantification by LC-MS/MS. They support enterprise workflows across quantitative proteomics, bioanalysis, biomarker validation, and regulated method development by correcting for variability introduced during sample preparation, separation, and mass spectrometric detection.

Quantitative Proteomics (Targeted LC-MS/MS)

Targeted Quantification: Heavy peptide internal standards support SRM/MRM and PRM workflows for accurate measurement of proteotypic peptides.

Multi-Analyte Panels: Stable isotope labeled peptide panels enable consistent quantification across pathways or biomarker sets in complex matrices.

Inter-Laboratory Reproducibility: Standardized heavy peptides improve comparability across sites, instruments, and study phases.

Workflow Control: Co-eluting standards help correct for ion suppression and instrument drift in routine proteomics operations.

Biomarker Verification and Translational Research

Biomarker Confirmation: Stable isotope labeled peptides provide reference points for verifying candidate biomarkers before larger-scale studies.

Quantitative Comparability: Heavy standards support longitudinal comparison across cohorts and timepoints sample sets.

Method Transfer Support: Well-characterized standards reduce variability during assay transfer between R&D teams and CROs.

Fit-for-Purpose Development: Enables assay optimization for sensitivity, selectivity, and dynamic range under realistic sample conditions.

Post-Translational Modification (PTM) Quantification

Phosphopeptide Standards: Heavy PTM peptides support site-specific quantification in signaling and pathway activation studies.

Control of Enrichment Bias: Internal standards can be applied to evaluate recovery and variability introduced by PTM enrichment methods.

Distinguishing Modification States: Labeled PTM standards help differentiate closely related modified forms in complex spectra.

Robust Reporting: Enables consistent quantification of PTMs that are sensitive to sample handling and analytical conditions.

Regulated Bioanalysis and Method Validation Support

Internal Standards for Validated Methods: Stable isotope labeled peptides are used to improve accuracy and precision in quantitative LC-MS/MS assays.

Documentation-Ready Materials: QC characterization and traceable documentation support internal qualification and method validation packages.

Routine Monitoring Programs: Long-term supply and lot consistency help maintain method performance across extended studies.

Cross-Site Program Continuity: Consistent standards reduce revalidation risk during site expansion or partner laboratory involvement.

Instrument Performance Monitoring and Assay Quality Control

System Suitability: Heavy peptide mixes can be used to monitor retention time stability, sensitivity, and response consistency.

Drift Detection: Supports early identification of instrument drift or matrix-driven ion suppression during routine operations.

QC Trending: Enables consistent tracking of assay performance metrics across batches and time.

Standardized Reference: Helps harmonize performance benchmarks across multiple instruments or laboratory sites.

Stable isotope labeled peptides are used to enhance LC-MS quantification accuracy by comparing light and heavy peptide standards, enabling precise concentration measurements. This process includes sample preparation, LC separation, mass spectrometry detection, and data analysis to obtain accurate quantitative results.

Start Your Stable Isotope Labeled Peptide Project Today

If your team needs reliable stable isotope labeled peptide standards for quantitative proteomics, biomarker verification, PTM analysis, or regulated LC-MS/MS method development, Creative Peptides can support your program with application-aligned design, controlled manufacturing, and thorough analytical qualification. Contact us to discuss peptide sequences, labeling strategy, purity requirements, documentation expectations, and long-term supply planning. Contact us today to request a technical consultation and quotation.

FAQs

Stable isotope-labeled peptides act as internal standards, enabling accurate quantification of target peptides or proteins. These labeled peptides improve detection sensitivity and dynamic range in mass spectrometry, while also allowing for multiplexing by using different isotopic labels to distinguish multiple samples within a single experiment, facilitating high-throughput analysis.

Stable isotope-labeled peptides are typically synthesized using solid-phase peptide synthesis (SPPS) techniques. During synthesis, amino acids containing stable isotopes are incorporated at specific positions within the peptide sequence. The resulting labeled peptides are then purified and characterized for use in mass spectrometry experiments.

Protein quantification can be approached in different ways, including relative quantification, which compares protein expression levels between different samples or conditions; absolute quantification, which determines the exact concentration of specific proteins; and targeted proteomics, which focuses on quantifying specific peptides or proteins of interest within complex biological samples.

Yes, many providers offer customization services where stable isotope-labeled peptides can be synthesized and optimized according to your specific experimental requirements, including peptide sequence, labeling scheme, and purity.

Turnaround times and costs can vary depending on the complexity of the synthesis, the quantity and purity of labeled peptides required, and the customization options. It's best to inquire with the service provider for specific details regarding turnaround times and pricing.

Yes, stable isotope-labeled peptides can be used with various mass spectrometry platforms, including triple quadrupole, quadrupole-time-of-flight (Q-TOF), and Orbitrap instruments, among others. Compatibility may vary depending on the labeling scheme and specific experimental protocols.

References

Becker GW. Stable isotopic labeling of proteins for quantitative proteomic applications. Briefings in Functional Genomics and Proteomics. 2008, 7(5): 371-382.

Kettenbach, A.N., et al. Absolute quantification of protein and post-translational modification abundance with stable isotope–labeled synthetic peptides. Nature Protocols. 2011, 6(2): 175.

Ong, S.E., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular & Cellular Proteomics. 2002, 1(5): 376-386.

Mueller, L.N., et al. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. Journal of Proteome Research. 2008, 7(01): 51-61.